Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.73
-0.64 (-6.83%)
At close: Nov 20, 2024, 4:00 PM
8.90
+0.17 (1.95%)
After-hours: Nov 20, 2024, 7:14 PM EST
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $596.93 million as of November 21, 2024. Its market cap has increased by 29.42% in one year.
Market Cap
596.93M
Enterprise Value
781.25M
1-Year Change
29.42%
Ranking
Category
Stock Price
$8.73
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $596.93M, an increase of 13.24%. That is a compound annual growth rate of 2.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 596.93M | 14.20% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | 935.68M | 22.51% |
| Dec 31, 2019 | 763.76M | 44.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ORIC Pharmaceuticals | 616.76M |
| Tourmaline Bio | 615.42M |
| Dianthus Therapeutics | 614.73M |
| Standard BioTools | 599.34M |
| Stoke Therapeutics | 599.06M |
| Immunome | 582.35M |
| IGM Biosciences | 580.67M |
| Altimmune | 572.55M |